The United States government is set to enter into a contract with pharmaceutical manufacturer Johnson & Johnson to purchase 100 million doses of the company's single-jab coronavirus vaccine, set to be administered during the second half of 2021.
According to CNBC, the U.S. President is expected to officially announce the...
The industry of electric vehicles is growing rapidly by the day, and thus there are countless companies battling to gain position for the head honcho spot. Tesla has always held a firm hold over its competitors in this field, but there's another company that experts are predicting will surprise...
Anglo-Dutch food delivery company JustEatTakeaway.com announced on Wednesday that it expects to realize another sales surge in 2021 following its skyrocketing full-year earnings for 2020. This initial surge in online orders was spurred by the lockdowns that came as a consequence of the coronavirus pandemic outbreak in March 2020.
JustEatTakeaway.com...
Australian health authorities revealed on Wednesday that the country is expected to complete its coronavirus vaccination drive by the end of October. With 100,000 vaccine doses having been administered since the start of the campaign, the Australian nation has expressed little concern over its relatively slow vaccination program, particularly...
A top South African health official revealed on Friday that the South African government is currently in talks with the African Union (AU) over the purchase of COVID-19 vaccines for 10 million people.
Before deciding to halt the rollout of its AstraZeneca shots, the South African government had previously...
Japanese holding company SoftBank has announced that it intends to double the number of users of its PayPay QR code payment app in the next three to four years. According to an executive at Z Holdings (SoftBank's internet subsidiary), the conglomerate is aiming to extend its lead in the...
Pharmaceutical manufacturer AstraZeneca has sold its entire 7.7% stake in U.S. biotech firm Moderna, raking in a revenue of more than $1 billion as a result. The English-Swedish company is looking to use the income from the sale to expand its own internal operations, namely by developing its own...
Multinational science and technology company Merck KGgA announced on Monday that it has closed a deal with Swiss biotech company Debiopharm to develop and market its Xevinapant drug for head and neck cancer. The deal is estimated to be worth 900 million euros ($1.08 billion).
The terms of the deal...
After 33 years of operational difficulties, American vaccine development company Novavax has finally received approval for its COVID-19 vaccine shot. According to testing results, the Novavax vaccine has efficacy rates that are of a similar level to the vaccines developed by Pfizer and BioNTech as well as Moderna.
As the...
Johnson & Johnson's single-dose coronavirus shot recently received emergency use approval from the U.S. Food and Drug Administration on Saturday evening, making it the third COVID vaccine available for use in the United States.
Following the conclusion of early-phase clinical trials, the pharmaceutical giant submitted data regarding its results to...